# Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast

> **NCT02749370** · PHASE4 · COMPLETED · sponsor: **Amgen** · enrollment: 80 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT02749370
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-18
- **Primary completion:** 2017-08-14
- **Final completion:** 2017-12-06
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02749370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02749370, "Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02749370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*